FR2385721A1 - Cyclopropyl-6 dihydro-1,3 methyl-1 phenyl-5 oxo-2 2 h-thieno (2,3-e) diazepine, son procede de preparation et son application en therapeutique - Google Patents

Cyclopropyl-6 dihydro-1,3 methyl-1 phenyl-5 oxo-2 2 h-thieno (2,3-e) diazepine, son procede de preparation et son application en therapeutique

Info

Publication number
FR2385721A1
FR2385721A1 FR7807697A FR7807697A FR2385721A1 FR 2385721 A1 FR2385721 A1 FR 2385721A1 FR 7807697 A FR7807697 A FR 7807697A FR 7807697 A FR7807697 A FR 7807697A FR 2385721 A1 FR2385721 A1 FR 2385721A1
Authority
FR
France
Prior art keywords
diazepine
thieno
cyclopropyl
dihydro
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7807697A
Other languages
English (en)
Inventor
Jean-Claude Cognacq
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hexachimie SA
Original Assignee
Hexachimie SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexachimie SA filed Critical Hexachimie SA
Publication of FR2385721A1 publication Critical patent/FR2385721A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/36—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Nouveau produit chimique à activité thérapeutique. Un tel produit est constitué par la cyclopropyl-6 dihydro-1,3 méthyl-1 phényl-5 oxo-2 2H-thiéno Ø2,3-eõ diazépine ainsi que ses sels d'addition d'acides non toxiques, de formule I. Application en thérapeutique humaine, notamment dans le traitement des affections gastro-duodénales.
FR7807697A 1977-03-31 1978-03-16 Cyclopropyl-6 dihydro-1,3 methyl-1 phenyl-5 oxo-2 2 h-thieno (2,3-e) diazepine, son procede de preparation et son application en therapeutique Withdrawn FR2385721A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1358777 1977-03-31

Publications (1)

Publication Number Publication Date
FR2385721A1 true FR2385721A1 (fr) 1978-10-27

Family

ID=10025687

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7807697A Withdrawn FR2385721A1 (fr) 1977-03-31 1978-03-16 Cyclopropyl-6 dihydro-1,3 methyl-1 phenyl-5 oxo-2 2 h-thieno (2,3-e) diazepine, son procede de preparation et son application en therapeutique

Country Status (17)

Country Link
US (1) US4156009A (fr)
JP (1) JPS53121791A (fr)
AR (1) AR215171A1 (fr)
AU (1) AU3495678A (fr)
BE (1) BE865278A (fr)
DD (2) DD143777A5 (fr)
DE (1) DE2813996A1 (fr)
DK (1) DK135478A (fr)
ES (2) ES468382A1 (fr)
FR (1) FR2385721A1 (fr)
GR (1) GR62853B (fr)
NL (1) NL7803431A (fr)
NO (1) NO781102L (fr)
PT (1) PT67813A (fr)
SE (1) SE7803604L (fr)
SU (1) SU715027A3 (fr)
ZA (1) ZA781694B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0225554D0 (en) * 2002-11-01 2002-12-11 Syngenta Participations Ag Chemical compounds

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2113955A1 (fr) * 1970-11-16 1972-06-30 Sumitomo Chemical Co
JPS49101394A (fr) * 1973-02-03 1974-09-25
JPS50142588A (fr) * 1974-05-02 1975-11-17

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1256548A (fr) * 1968-12-10 1971-12-08
CA927388A (en) * 1970-02-17 1973-05-29 Nakanishi Michio Thieno (2,3-e)(1,4)diazepin-2-ones
US3806512A (en) * 1970-09-03 1974-04-23 Yoshitomi Pharmaceutical 2-amino-3-pyridylcarbonylthiophene compounds
US3872089A (en) * 1971-05-14 1975-03-18 Hoffmann La Roche Substituted thienodiazepines
GB1345998A (en) * 1971-05-31 1974-02-06 Yoshitomi Pharmaceutical Thienodiazepine compounds and pharmaceutical compositions containining them

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2113955A1 (fr) * 1970-11-16 1972-06-30 Sumitomo Chemical Co
JPS49101394A (fr) * 1973-02-03 1974-09-25
JPS50142588A (fr) * 1974-05-02 1975-11-17

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CA1975 *
CA1976 *

Also Published As

Publication number Publication date
NL7803431A (nl) 1978-10-03
US4156009A (en) 1979-05-22
BE865278A (fr) 1978-09-25
GR62853B (en) 1979-06-20
DD143777A5 (de) 1980-09-10
DK135478A (da) 1978-10-01
PT67813A (fr) 1978-04-01
AR215171A1 (es) 1979-09-14
AU3495678A (en) 1979-10-18
SU715027A3 (ru) 1980-02-05
DD137108A5 (de) 1979-08-15
SE7803604L (sv) 1978-10-01
ZA781694B (en) 1979-03-28
ES477164A1 (es) 1979-10-16
JPS53121791A (en) 1978-10-24
NO781102L (no) 1978-10-03
DE2813996A1 (de) 1978-10-05
ES468382A1 (es) 1979-10-01

Similar Documents

Publication Publication Date Title
Esterly et al. Neutrophil chemotaxis in patients with acne receiving oral tetracycline therapy
NO852872L (no) Fremgangsmaate for fremstilling av nye tetrapyrroler.
ATE62414T1 (de) Mittel zur behandlung von herzerkrankungen.
ES478967A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7.
DE58901002D1 (de) Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken.
Levy The activity of chaulmoogra acids against Mycobacterium leprae
NO175885C (no) Fremgangsmåte for fremstilling av et salicylsyreholdig middel for lokal behandling av hudsykdommer med avskalling
FR2385721A1 (fr) Cyclopropyl-6 dihydro-1,3 methyl-1 phenyl-5 oxo-2 2 h-thieno (2,3-e) diazepine, son procede de preparation et son application en therapeutique
US4801444A (en) Medicinal preparation for individual prevention of venereal diseases and treatment of urogenital trichomoniasis
FR2367737A1 (fr) Polypeptide, son procede de preparation et medicament le contenant
ES8205190A1 (es) Un procedimiento para la preparacion del acido 3,7,11,15-tetrametil-2,4,6,10-14-hexadecapentaenoico.
RU94006580A (ru) Адаптоген трекрезан в медицине
US5391546A (en) Composition comprising organo-silicon compounds for therapeutic use
US4994445A (en) Substances with therapeutic applications comprising organo-silicon compounds
Burns et al. The significance of coral-red fluorescence of the skin
Ostrander et al. A clinical study of the treatment of root canal and periapical infections with penicillin
US3655881A (en) Method of treating burned skin
SU1832496A1 (ru) Антисептическое средство профилактики венерических заболеваний "мирамистин"
Rosenberg et al. Single-dose ceftriaxone treatment of urinary tract infections
Price et al. Oral talampicillin in the treatment of gonorrhoea.
Bernheim et al. Carcinogens and oxidized fatty acids in the skin
Redewill Streptomycin in the successful treatment of tuberculosis of the urinary bladder: Report of 2 cases
SU1487907A1 (ru) Способ лечения овуляторных болей
RU2132187C1 (ru) Способ лечения заболеваний кожи и слизистых оболочек и магнитоактивное органическое соединение железа, используемое в нем
RU2134098C1 (ru) Способ лечения воспалительных заболеваний пародонта

Legal Events

Date Code Title Description
ST Notification of lapse